Brain perfusion follow-up in Alzheimer's patients during treatment with acetylcholinesterase inhibitors.
UNLABELLED: Transient cognitive and behavioral stabilization of patients with Alzheimer's disease (AD) is the main goal of long-term acetylcholinesterase inhibitor (AChEI) therapy, but response to treatment is variable and, indeed, only some of the patients are stabilized. This is usually asse...
Main Authors: | Nobili, F, Koulibaly, M, Vitali, P, Migneco, O, Mariani, G, Ebmeier, K, Pupi, A, Robert, P, Rodriguez, G, Darcourt, J |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2002
|
Similar Items
-
Automatic classification of SPECT images of Alzheimer's disease patients and control subjects
by: Stoeckel, J, et al.
Published: (2004) -
Using SPM as a diagnostic help with HMPAO-SPECT in Alzheimer's disease
by: Ebmeier, K, et al.
Published: (2001) -
Human brain acetylcholinesterase
by: Novales-Li, P
Published: (1993) -
Decreased CSF acetylcholinesterase activity in Alzheimer's disease.
by: Appleyard, M, et al.
Published: (1983) -
Effects of a single dose of the acetylcholinesterase inhibitor velnacrine on recognition memory and regional cerebral blood flow in Alzheimer's disease.
by: Ebmeier, K, et al.
Published: (1992)